Immunosuppression Increases Risk of HPV-related Cancers in AIDS Patients(8/20/2009) The risk of HPV-related cancers is elevated among AIDS patients. This risk continues to increase as patients’ immune systems become more compromised, according to the results of a study published in the Journal of the National Cancer Institute.
Colorectal Cancer Screening for Individuals with HIV(8/24/2006) According to an article recently published in the Archives of Internal Medicine, patients with the human immunodeficiency virus (HIV) over the age of 50 years may have a higher rate of colon cancer than healthy individuals and should be screened for this disease.
Addition of Rituxan® to CHOP Safe and Effective for AIDS-related NHL(8/16/2006) According to an early online publication in the Journal of Clinical Oncology, the addition of Rituxan® (rituximab) to the chemotherapy combination known as CHOP is safe and effective for the treatment of AIDS-related non-Hodgkin's lymphoma.
Metastat® Shows Promise Against AIDS-related Kaposi’s Sarcoma(3/24/2006) According to the results of a phase II clinical trial published in the Journal of Clinical Oncology, treatment with Metastat® (COL-3) reduced or eliminated detectable Kaposi’s sarcoma in some patients with acquired immune deficiency syndrome (AIDS).